Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-02-12 Sale |
2024-02-12 4:44 pm |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
73,274 | $0 | $0 | 0 (Direct) |
View |
2024-02-05 Sale |
2024-02-06 9:47 pm |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
4,583 | $29.3 | $134,282 | 101,974 (Direct) |
View |
2023-11-30 Sale |
2023-12-05 9:08 pm |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
3,826 | $29.2 | $111,719 | 33,140 (Direct) |
View |
2023-11-15 Sale |
2023-11-17 7:52 pm |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
108,609 | $16.04 | $1,741,959 | 574,342 (Direct) |
View |
2023-08-09 Sale |
2023-08-11 5:02 pm |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
100,210 | $14.2 | $1,422,982 | 86,169 (Direct) |
View |
2023-08-02 Sale |
2023-08-04 7:33 pm |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
84,581 | $17.1 | $1,446,659 | 442,124 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-08-27 Option Award |
2024-08-27 7:51 pm |
N/A 2034-08-26 |
FibroBiologics Inc. | FBLG | Coen Stacy Ann Director |
5,000 | $0 | 5,000 (Direct) |
View |
Ownership(A) |
2024-08-13 4:01 pm |
N/A 2033-02-16 |
FibroBiologics Inc. | FBLG | Coen Stacy Ann Director |
0 | $0 | 190,300 (Direct) |
View |
Ownership |
2024-02-13 6:30 pm |
N/A N/A |
FibroBiologics Inc. | FBLG | Coen Stacy Ann Director |
0 | $0 | 7,500 (Direct) |
View |
2024-02-02 Exercise |
2024-02-06 9:47 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
14,350 | $0 | 101,974 (Direct) |
View |
2024-02-01 Option Award |
2024-02-05 9:26 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
39,293 | $0 | 39,293 (Direct) |
View |
2023-12-29 Option Award |
2024-01-03 5:51 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
367 | $16.01 | 366,972 (Direct) |
View |
2023-12-29 Exercise |
2024-01-03 5:51 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
30,000 | $5.32 | 366,972 (Direct) |
View |
2023-12-29 Exercise |
2024-01-03 5:51 pm |
N/A 2032-02-04 |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
30,000 | $0 | 366,972 (Direct) |
View |
2023-11-15 Exercise |
2023-11-17 7:52 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
82,223 | $7.69 | 574,342 (Direct) |
View |
2023-11-15 Exercise |
2023-11-17 7:52 pm |
N/A 2030-06-01 |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
108,609 | $0 | 574,342 (Direct) |
View |
2023-11-15 Exercise |
2023-11-17 7:52 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
26,386 | $4.92 | 574,342 (Direct) |
View |
2023-09-08 Exercise |
2023-09-11 4:08 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
26,006 | $7.69 | 195,976 (Direct) |
View |
2023-09-08 Exercise |
2023-09-11 4:08 pm |
2022-02-05 2031-02-05 |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
26,006 | $0 | 195,976 (Direct) |
View |
2023-08-09 Exercise |
2023-08-11 5:02 pm |
2021-06-01 2030-06-01 |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
100,210 | $0 | 86,169 (Direct) |
View |
2023-08-09 Exercise |
2023-08-11 5:02 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
100,210 | $4.92 | 86,169 (Direct) |
View |
2023-08-02 Exercise |
2023-08-04 7:33 pm |
2021-06-01 2030-06-01 |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
84,581 | $0 | 442,124 (Direct) |
View |
2023-08-02 Exercise |
2023-08-04 7:33 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
84,581 | $4.92 | 442,124 (Direct) |
View |
2023-06-30 Option Award |
2023-07-05 5:55 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
3,792 | $4.05 | 10,960 (Direct) |
View |
2023-02-03 Option Award |
2023-02-07 5:21 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
286,900 | $0 | 286,900 (Direct) |
View |
2022-05-20 Option Award |
2022-12-27 5:18 pm |
2022-05-20 2030-06-01 |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
90,000 | $0 | 120,000 (Direct) |
View |
2022-06-30 Option Award |
2022-07-05 4:33 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
3,342 | $3.825 | 7,168 (Direct) |
View |
2022-02-04 Option Award |
2022-02-08 5:26 pm |
2023-02-04 2032-02-04 |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & Chief Business Officer |
333,465 | $5.32 | 333,465 (Direct) |
View |
2021-12-31 Option Award |
2022-01-04 4:06 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Coen Stacy Ann SVP & Chief Business Officer |
1,496 | $5.6 | 3,826 (Direct) |
View |
2021-06-30 Option Award |
2021-07-02 4:20 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Coen Stacy Ann Chief Business Officer |
2,330 | $5.52 | 2,330 (Direct) |
View |
2021-02-05 Option Award |
2021-02-09 8:11 pm |
2022-02-05 2031-02-05 |
ImmunoGen Inc. | IMGN | Coen Stacy Ann Chief Business Officer |
185,016 | $7.69 | 185,016 (Direct) |
View |
2020-06-01 Option Award |
2020-06-04 1:09 pm |
2021-06-01 2030-06-01 |
ImmunoGen Inc. | IMGN | Coen Stacy Ann Chief Business Officer |
260,000 | $4.92 | 260,000 (Direct) |
View |